High levels of stromal cell-derived factor-1 α predict short-term progression of renal dysfunction in patients with coronary artery disease
ConclusionHigh plasma levels of SDF-1 α were associated with the short-term decline of eGFR in patients with CAD. Thus, SDF-1α may be useful for predicting the progression of renal dysfunction in patients with CAD.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
More News: Cardiology | Cardiovascular | Chronic Kidney Disease | Heart | Study | Urology & Nephrology